Costly Transgender Procedures Funded By Taxpayer

Source:

MEDIA RELEASE

16 December 2024  

According to an Official Information Act response from Health NZ / Te Whatu Ora, the taxpayer is funding more than $1 million dollars each year towards enabling people to surgically change their sex via vaginoplasty, metoidioplasty and phalloplasty procedures. The demand is higher for the removal of the penis, testicles and scrotum. Demand for these surgical procedures is predominantly in the 18-25 and 26-35 age brackets.

According to Te Whatu Ora, “Of the 326 patients on the waiting list, 243 have requested a feminising procedure and 83 a masculinising procedure. Therefore, it can be assumed of the sex assigned at birth of these patients 243 were assigned male at birth and 83 assigned female at birth.” (our emphasis added)

Age ranges of the 326 patients are:

18–25               94

26-35               148

36-45               51

46-55               22

>55                    11

Vaginoplasty involves removing the healthy penis, testicles and scrotum to create a vulva and vagina.

Metoidioplasty involves creating a penis about 4 to 6 centimeters long using the clitoris, which may be enlarged by hormone therapy. The surgery can be completed in stages, each performed a few months apart, depending on the patient’s objectives.

Phalloplasty uses a tissue flap from the arm or thigh to create a larger phallus that can accommodate a penile prosthesis and penetration. Phalloplasty is a multistage operation, with urethroplasty to enable standing urination performed later. Phalloplasty is complex and has a higher risk of complications, including infection, scarring, and narrowed urethra.

Despite the relatively small number of surgeries actually performed, the cost is significant.

[Where the number of individuals is less than five, Health New Zealand used <5 to avoid revealing sensitive information about potentially identifiable individuals in the data. It is also important to note that some patients may require more than one procedure.]

Health NZ were unable to quantify the costs of mental health assessment, psychiatric support or counselling – if these even occurred.

A Swedish study followed a transgender group of adults from 1973-2003. This study found:

Persons with transsexualism, after sex reassignment, have considerably higher risks for mortality, suicidal behaviour, and psychiatric morbidity than the general population. Our findings suggest that sex reassignment, although alleviating gender dysphoria, may not suffice as treatment for transsexualism, and should inspire improved psychiatric and somatic care [restore the natural balance within the body-mind system to resolve physical and mental stress) after sex reassignment for this patient group.

And a recent Finnish study said:

“Although the rate of suicide [in the Finnish study] is just over four times higher among trans young people than their peers, this is explained by their more serious psychiatric problems. When these psychiatric problems are taken into account, there is no evidence that transgender people have a higher rate of suicide.”

This Finnish study vindicates their decision four years ago to adopt a more cautious treatment policy which first targets psychiatric, social and educational problems among gender-distressed youth before any assumption of a stable trans identity justifying “experimental” affirmation with hormones or surgery.

The researchers say in their BMJ Mental Health paper; “It is of utmost importance to identify and appropriately treat mental disorders in adolescents experiencing gender dysphoria to prevent suicide; in addition, health policies need to ensure that accurate information is provided to professionals along these lines,”

A study published in April entitled “Risk of Suicide and Self-Harm Following Gender-Affirmation Surgery” evaluated patient data from nearly 60 U.S. health care organisations, comprising millions of patients. The study concluded: “Individuals who underwent gender-affirming surgery had a 12.12-fold higher suicide attempt risk than those who did not.” Those who had undergone gender-transition surgeries were nearly five times more likely to attempt suicide than those who had undergone tubal ligations or vasectomies, the study found. It warned: “Gender-affirming surgery is significantly associated with elevated suicide attempt risks, underlining the necessity for comprehensive post-procedure psychiatric support.”

What is most concerning is that the demand for these unnecessary operations here in New Zealand is only likely to increase.

According to Official Information Act data gained by Family First from the Department of Internal Affairs, almost 900 people in total have changed their birth certificates to their ‘self-identified gender’ since the new birth certificate law came into force last year. Children are changing the sex on their birth certificate, including 47 children 15 years or younger.

Demand to be recognised as a female was greatest with 445, followed by male 302, and non-binary 142.

Health NZ say that since 2020 the service has been publicly funded to deliver up to 14 gender affirming genital surgeries (either feminising or masculinising) per year.

In a poll at the end of 2018, 63% opposed taxpayer funding for hormone treatment and surgery for people who wished to change their sex. 27% supported it, and a further 11% were unsure or refused to say.

Legal Advice Tells Health Ministry to Pause Puberty Blockers

Source:

MEDIA RELEASE

13 December 2024

Family First has written to the Director-General of Health Dr Diana Sarfati requiring the Ministry of Health to remove the reference to the PATHA Guidelines in the Position Statement on the Use of Puberty Blockers in Gender-Affirming Care issued by the Ministry on 21 November 2024.

Family First has been legally advised that such a reference may be illegal.

The Guidelines for Gender Affirming Health care for Gender Diverse and Transgender Adults in Aotearoa New Zealand written by activists from PATHA makes statements on puberty blockers which are not supported by the findings from the Ministry’s own evidence brief, as summarised in the Position Statement on the Use of Puberty Blockers in Gender-Affirming Care, nor by other probative evidence.

The consent forms in the appendices to the PATHA guidelines also state: “Blockers are a reversible medication used to stop the physical changes of puberty. It can be started in early puberty (Tanner stage 2–3). This position is reinforced by the reference in the Health NZ website to PATHA under “Resources for transgender New Zealanders and their whanau”.

Not removing the reference to the independent PATHA Guidelines is also inconsistent with the Position Statement stating that “Clinicians will continue to provide careful guidance to and follow up for people and families considering gender-affirming care.”

Family First has advised the Director General that there are four reasons why failure to remove reference to the PATHA Guidelines may be illegal:

  • the findings of the Evidence Brief mean that the PATHA Guidelines include fundamental mistakes of fact. Those Guidelines confidently state that puberty blockers are safe and reversible (and effective). Yet the Position Statement found that there is no quality evidence to support any of these findings. This leads to a lack of informed consent
  • the Ministry of Health is effectively advising Doctors, parents, and young people over 16 that the PATHA Guidelines are safe and factually accurate guidelines to use in the interim while the Ministry works with Health NZ to devise clinical guidelines.
  • the consent form does not set out the risks of harm due to the lack of quality research about lack of harm and reversibility. The PATHA Guidelines say puberty blockers are safe and reversible as does the consent form you sign to start “treatment.” The potential breaches of sections 8-10 of the Bill Of Rights Act (BORA) must be viewed in the factual context that the Court of Appeal in the UK has found regarding puberty blockers: “the clinical interventions involve significant, long-term and, in part, potentially irreversible long-term physical, and psychological consequences for young persons.
  • the reference to the PATHA Guidelines in the Ministry’s Position Statement breaches the United Nations Convention on the Rights of the Child (UNCROC). The misinformation in the PATHA Guidelines and included consent forms are not in the best interests of children under UNCROC.

Family First believes for these legal reasons alone, it is critical that the Ministry act immediately and make regulations under the Medicines Act to stop the prescribing of puberty blockers for delaying puberty in gender incongruent or gender dysphoric young people because there is insufficient quality evidence that puberty blockers are both safe and reversible and efficacious in the treatment of gender dysphoria.

The letter has also been sent to the Minister of Health Dr Shane Reti and Associate Ministers of Health Matt Doocey, Casey Costello and David Seymour.

MEDIA RELEASE: Warnings of Wild West Of Medicinal Cannabis

Source:

Warnings of Wild West Of Medicinal Cannabis

Family First is calling for caution around the use of medicinal cannabis which, when loosely regulated, can result in mental and behavioural disorders due to use of cannabinoids and psychotic episodes.

According to data obtained under the Official Information Act by Family First in August, New Zealand health authorities say that 461 patients have had a primary diagnosis of Mental and behavioural disorders due to use of cannabinoids, psychotic disorder in the last recorded 12-month period (22/23) – rising from 376 in 2019/20 – an increase of 23% over four years.

According to a recent report in Australia, “doctors are warning of a significant increase of people ending up in hospital with psychosis after being prescribed the drug. Their concerns come amid a proliferation of “single-issue” cannabis clinics setting up in Australia, some of them willing to prescribe via telehealth consultations with few checks. Brett Emmerson, Queensland chair of the Royal Australian and New Zealand’s College of Psychiatrists, says the college wants stronger regulations of medicinal cannabis products and prescribing practices.”

This is now a prospect for New Zealand, as reported in Newsroom today. Telehealth provider Dispensed which offers medical cannabis to patients through questionnaires and online appointments wants to set up shop in New Zealand.

It appears that Big Marijuana wants to sneak into New Zealand via the smokescreen of medicinal cannabis – which we always warned would happen. Combined with high-THC products, we are setting up the perfect storm of health and social problems associated with the drug.

The prescriptions for ‘medicinal’ cannabis is increasing in New Zealand, increasing from 22,506 in 2021 to 108,000 last year and 160,000 in the most recent period.

But it appears that the industry is becoming the wild west with high potency THC products being made available. During the Referendum in 2020, Patrick Gower found growers who were manufacturing a concentrated cannabis resin (dab) with an incredibly potent 81 percent tetrahydrocannabinol (THC).

Dr Marta Rychert, a senior researcher at Massey University who with co-author Associate Professor Chris Wilkins have just published NZ Medical Journal: Implementation of the Medicinal Cannabis Scheme in New Zealand: six emerging trends warn about the increasing prevalence of products high in THC, and the rise of private cannabis clinics.

Dr Rychert says “My hope is that cannabis clinicians prescribe responsibly.” But medicine should never be based on ’hoping’ that clinicians do the right thing, especially when it comes to such a controversial ‘medicine’.

Just last week, two men in Australia with mental health conditions were prescribed medical cannabis by a pharmacist who founded a medicinal cannabis company . One was hospitalised with psychosis, the other took his own life.

There are justified concerns about the prevalence of online prescriptions without adequate patient-doctor interactions. The report says that while medicinal cannabis is legal in Australia for certain conditions like severe childhood epilepsy and cancer-related vomiting, it’s often prescribed for anxiety and insomnia despite lacking evidence of effectiveness.

In 2021, the Faculty of Pain Medicine at the Australian and New Zealand College of Anaesthetists (ANZCA) said that there is no robust evidence from gold-standard studies that proves cannabinoid products effectively treast chronic non-cancer pain.

A significant study released at the time of the referendum found that “people who smoked marijuana on a daily basis were three-times more likely to be diagnosed with psychosis compared with people who never used the drug. For those who used high-potency marijuana daily, the risk jumped to nearly five-times.” By “high-potency” the researchers meant marijuana with THC content of just 10%+.

A study released in 2017 in the US and published in the journal JAMA Psychiatry found that marijuana use and marijuana use disorders – in which people use the drug in unhealthy or abusive ways – increased at a “significantly greater rate” in states with medical marijuana laws than in states without the laws.

Family First has always supported the expansion of further quality research into the components of the marijuana plant for delivery via non-smoked forms (‘medicinal cannabinoids’ products), and the establishment of a programme that allows seriously ill patients to obtain other non-smoked components of marijuana approved and listed by the Ministry of Health via their GP – but with appropriate regulation around safety and efficacy.

The Health Ministry needs to step up and ensure robust monitoring and enforcement of this new industry.
ENDS

WWF Statement on Wildlife Innovation and Longevity Driver Reauthorization (WILD) Act

Source:

The House of Representatives on Monday passed the Wildlife Innovation and Longevity Driver Reauthorization (WILD) Act, which would reauthorize critical U.S. Fish and Wildlife conservation programs for five years, including the Multinational Species Conservation Funds to conserve some of the world’s most iconic species. In response, World Wildlife Fund (WWF) issued the following statement from Alejandro Pérez, senior vice president of policy and government affairs:

“Renewal of the Multinational Species Conservation Funds will ensure the U.S. continues to lead global efforts to protect endangered elephants, rhinos, tigers, great apes, and sea turtles in the wild. The strong bipartisan support for the WILD Act in today’s House vote is a testament to the effectiveness of these programs and the unifying power of efforts to conserve wildlife around the world. WWF thanks Reps. Dave Joyce and Debbie Dingell for their leadership to advance the WILD Act and urges the Senate to pass this important legislation without delay.”

WWF statement on White House announcing pause of liquid natural gas export approvals

Source:

The Biden administration announced Friday a temporary pause on pending decisions on exports of liquid natural gas until the Department of Energy updates how it makes such authorizations. The revised approval process is expected to better account for the climate impacts of natural gas. In response, World Wildlife Fund (WWF) issued the following statement from Marcene Mitchell, senior vice president of climate:

“The administration’s decision to pause approving additional liquid natural gas export facilities is the right one, and an important step in the transition away from our reliance on fossil fuels. We would encourage the administration to work with private sector partners to further decrease liquid natural gas exports in order to support the global transition toward clean energy sources.”

WWF Statement on the 50th Anniversary of the Endangered Species Act

Source:

Today, World Wildlife Fund (WWF) commemorates the 50th anniversary of the Endangered Species Act. To celebrate, WWF has released the following statement:

Today marks the 50th anniversary of the Endangered Species Act, one of the nation’s bedrock environmental laws. Since 1973, the Endangered Species Act has prevented 99% of its listed species from extinction and has served as a global model for responsible wildlife protection. The Act represents one of the most significant innovations in conservation due to its comprehensive protection for species and their habitats, its science-based approach, its citizen engagement, interagency cooperation and the development of recovery plans and programs.

The Endangered Species Act plays a vital role in maintaining biodiversity which is crucial for ecosystem resilience and human health and wellbeing. It is increasingly important in the context of climate change, as shifting climates add additional stress on already struggling threatened and endangered wildlife.

World Wildlife Fund is deeply committed to amplifying the impact of the Endangered Species Act, and of the people whose lives and livelihoods depend upon its success. We work with local communities to implement conservation solutions that advance recovery of listed species like the black-footed ferret, one of North America’s most endangered mammals. The Endangered Species Act enabled the establishment of captive breeding programs and reintroductions to facilitate black-footed ferret recovery. Black-footed ferrets are on the brink of extinction due to habitat loss and sylvatic plague, a non-native disease lethal to both ferrets and prairie dogs, their main prey. Currently, there are about 390 ferrets in the wild, which is far below the 3,000 needed to achieve recovery.

Novel techniques and tools, including thermal cameras to detect ferrets at night and plague-protecting baits and vaccines, are vital to safeguarding this species. Thanks to the Endangered Species Act and collective efforts of many partners and innovative interventions, this masked bandit of the prairie now has a second chance to survive and thrive. On this day, WWF thanks and celebrates our partnerships with Native Nations, federal, state, and private entities, who are guiding the work to restore black-footed ferrets.

This anniversary of the Endangered Species Act underscores the importance of continued commitment, innovative conservation strategies, and ambitious cooperation to ensure that endangered species are protected for future generations. The 50th anniversary of the Endangered Species Act is a chance to reflect on the progress made and strengthen our resolve to address the complex ecological issues of our time.

WWF-US statement on COP28: Long-awaited acknowledgement, but fails to meet the moment for decisive action

Source:

Last week, the UNFCCC released the cover decision from COP28 in Dubai. In response, World Wildlife Fund (WWF) released the following statement from Marcene Mitchell, senior vice president of climate change:

For the first time, the final decision of the UNFCCC COP28 contains a commitment to transition away from fossil fuels. While this provides a long-awaited acknowledgment that the burning of coal, oil and gas is the main cause of global warming, the language falls short of a clear call for the phase out of all fossil fuels. The agreed upon language remains insufficient to meet the moment and requires further global action to keep 1.5°C alive in this decisive decade. We must persist with necessary urgency and not fall back on unrealistic promises that carbon capture technologies or “transition fuels” will solve the climate crisis.

We know from our lived experiences that floods, heat waves, storms and wildfires are threatening our way of living. Across the globe, 2 billion people are living through drought that threatens food and water security that can quickly become the source of political conflict and regional instability. We must put aside excuses and act on the need to leave our fossil fuel powered past behind.

The early decision at COP to operationalize the Loss and Damage fund for climate vulnerable nations was an important step in the right direction. So was the pledge by 130 countries to triple the amount of renewable energy deployed and double the rate of energy efficiency. This must be followed up by more ambition and funding to help countries adapt to rising temperatures and preserve nature as our main ally in the fight against climate change. As we leave Dubai and prepare for COP29 in Baku, we must move the needle on carbon pollution. The tide has turned on the era of fossil fuels and now is the time to secure a livable future for ourselves, our children and our planet.

WWF Releases its 4th Annual Transparent Report, Unveiling Progress on Plastic Footprints for Several of the World’s Biggest Brands

Source:

Today, World Wildlife Fund’s ReSource: Plastic program released its fourth annual public report, Transparent 2023, revealing how some of the world’s largest brands are tracking, measuring, and reporting on their respective plastic footprints. The data compiled in the report reveals insights and in-depth recommendations on tackling plastic waste within internal, corporate supply chains, and across wider multi-stakeholder efforts. The elimination of unnecessary, single-use plastic continues to be the most important action that companies can take to directly address the plastic pollution crisis through their own portfolios.

Transparent 2023 examines the plastic footprints of ReSource Members Amcor, Colgate-Palmolive, CVS Health, Kimberly-Clark Corporation, Keurig Dr Pepper, McDonald’s Corporation, Procter & Gamble, Starbucks, and The Coca-Cola Company. The report captures each company’s plastic by polymer type and form, their use of recycled content and sustainably sourced biobased content, and the likely waste management pathways for the aggregate portfolio. The comprehensive report includes progress made by each ReSource Member from 2021 to 2022 and compares year-over-year results for legacy Members.

“All companies should be reporting on their plastic footprint—something we are advocating for in the UN Global Treaty to End Plastic Pollution,” said Erin Simon, vice president of plastic waste + business at World Wildlife Fund. “ReSource Member companies are ahead of the curve, demonstrating that plastic reporting is not an onerous or impossible task. Their transparency enables lessons to be learned and actions to be taken that will reverberate across supply chains and industries worldwide.”

For the first time, ReSource is collecting comprehensive data from its Members on reuse efforts with the hope of sharing learnings on the best ways to eliminate plastic waste. WWF sees reuse systems emerging as a key strategy, with all nine Members exploring reuse in some capacity. This year’s Transparent report also measured progress and captured invaluable insights across four areas, including: eliminating unnecessary plastic, doubling global recycling and composting, shifting to sustainable inputs for remaining plastic, and improving data harmonization.

As for the 2023 key findings, please see the below top-level highlights:

  • Five ReSource
    Members saw an overall reduction in their virgin fossil-based plastic tonnage from 2021 to 2022.
  • Of the nine Members, four have reduced and five have increased their absolute tonnage of plastic since their baseline.
  • Despite progress in some areas, the total weight of plastic in the aggregate portfolio increased by 0.8% to 7.26 million metric tons in 2022 from 7.20 million metric tons in 2021.
  • Overall, ReSource Members have made progress to reduce problematic plastics. In 2022, these products made up 1.2% of Member portfolios, which is less than half of the 3.2% in the 2018 baseline year.
  • Among ReSource Members, the use of recycled content has increased to 12% in 2022 from 10.2% in 2021.
  • The share of packaging that is recyclable has increased to 72.5% in 2022 from 70.4% in 2021.

Learn more about how ReSource measures and analyzes data through the ReSource Footprint Tracker here.

WWF recently joined the Steering Committee of the Scaling Plastics Disclosure initiative to inform and support the expansion of the CDP’s plastic questionnaire. As the CDP questionnaire becomes increasingly robust and comprehensive, our intent is for it to replace the mandatory annual reporting for ReSource Members that currently occurs through the ReSource Footprint Tracker. As part of the Scaling Plastics Disclosure initiative and ReSource: Plastic, the ReSource Footprint Tracker serves as a tool for companies wishing to understand not only the amount and the kinds of plastics they are releasing into the market, but also the waste and leakage being generated as a result. It also provides a common framework for companies to report on their plastic impact.

Understanding the scope of the problem through plastic reporting is the first step to addressing plastic pollution. ReSource
Members are demonstrating that plastic reporting is possible. However, voluntary corporate action is not sufficient to address the scale and urgency of the plastic waste crisis. National and international policy action, through a legally binding Global Treaty to End Plastic Pollution and Extended Producer Responsibility legislation, is critical to ensuring a future free of plastic waste. Six out of nine Members are actively engaged in the Global Treaty process.

To view the full report, click here. To view the executive summary, click here.

About World Wildlife Fund (WWF)

WWF is one of the world’s leading conservation organizations, working in nearly 100 countries for over half a century to help people and nature thrive. With the support of more than 5 million members worldwide, WWF is dedicated to delivering science-based solutions to preserve the diversity and abundance of life on Earth, halt the degradation of the environment and combat the climate crisis. Visit http://www.worldwildlife.org to learn more and keep up with the latest conservation news by following @WWFNews on Twitter and signing up for our newsletter and news alerts here.

ReSource: Plastic Member Quotes

Amcor

“In addition to doing our job of helping to deliver products safely, we also make our packaging more circular by designing for recyclability, lowering the demand for virgin resources and using more recycled content. We have increased our target on recycled content use across the Amcor portfolio to 30% by 2030 and were the first global packaging company to pledge to design all our products to be recyclable, compostable or reusable by 2025.” He added, “However, all of us in the packaging value chain need to work together to ensure that recycling infrastructure is in place, feasible reuse systems are introduced, and that consumers are engaged to use those systems to return used packages to be recycled or used over and over again.” — David Clark, Amcor’s Vice President of Sustainability.

Colgate

“At Colgate-Palmolive we are excited to continue our partnership with WWF’s ReSource program. WWF and our peer companies have worked hard to facilitate a key collaborative network that moves forward our sustainability ambition to Eliminate Plastic Waste. The WWF ReSource program is also supporting our collective work toward an ambitious UN Plastic Pollution Treaty.” -Ann Tracy, CSO

Keurig Dr Pepper

“Keurig Dr Pepper’s packaging strategy is centered on advancing the use of more sustainable packaging materials and designs that use less virgin plastic. We continue to make progress against our ambitious 2025 sustainable packaging goals, including the increase of post-consumer recycled content across our plastic packaging from 11% in 2021 to 18% in 2022. We appreciate the WWF’s ReSource: Plastic program with data-driven recommendations to help drive industry focus on high impact actions.” – Charlie Schwarze, Senior Director of Sustainability, Keurig Dr Pepper

The Coca Cola Company

“In partnership with others, we are addressing the critical issue of packaging waste. Our goal is to help create a circular economy by 2030 where we get every bottle back so that none of it ends up as litter or in the oceans. We’ve set ambitious packaging goals for our business to help eliminate waste and increase reuse across the Coca-Cola system. We have made progress and recognize we have much more to do. We know by partnering with other organizations and across sectors, we can achieve more. That’s why we support a global treaty on marine plastic pollution and well-designed Extended Producer Responsibility legislation. We believe these efforts will help drive a more consistent approach to recycling infrastructure planning, investment and implementation across the world.” — Michael Goltzman, Global Vice President, Public Policy, Environmental Sustainability and Social Impact

Starbucks

“At Starbucks, our environmental promise to give back more than we take from the planet underpins our efforts to cut our waste, water, and carbon footprints in half by 2030. To further our waste reduction, we’ve continued our shift toward reusables, with 20 reusable cup tests in markets around the world, as well as industry-leading single-use packaging solutions, like the recent roll out of our FSC-certified single-use cup made with 30% recycled material and 25% less plastic in the liner and our transition to 100% rPET Ethos water bottles in US and Canada. As we look to the future to meet our ambitious goals, programs like ReSource are key for collaboration across sectors to drive meaningful progress,” – Starbucks chief sustainability officer, Michael Kobori.

BNZ cuts home loan rates, offers market-leading 18-month fixed rate

Source:

BNZ today cut interest rates across a number of home loan terms, with a market-leading 18-month fixed rate of 4.95% p.a.*

BNZ’s rates include 5.49% p.a. for 6 months, 4.99% p.a. for 1 year, and 4.99% p.a. for 2 years. The new rates are available from today for both new customers and existing customers who are eligible to refix.

BNZ General Manager Home Lending James Leydon says these competitive rates respond to customers’ diverse home loan needs, giving customers more options as they navigate the current interest rate environment.

“We know many of our customers are looking beyond the very short-term fixed rates as the interest rate environment evolves. By offering a market-leading 18-month option, we’re giving customers more choice and the ability to lock in a competitive rate for a longer period,” he says.

“At the same time, we continue to compete hard for those New Zealanders who prefer the flexibility of our 6-month and 1-year fixed rate options. With fixed rates reduced across multiple terms, we’re providing solutions that work for a wide range of borrowers.

“It’s also a timely Easter bonus for homeowners, when household budgets can face a bit of extra pressure from those extra school holiday costs.”

The changes follow BNZ’s announcement last week that it will cut its floating home loan rates by 25 basis points, following the Reserve Bank’s OCR reduction.

BNZ lending criteria (including minimum equity requirements), and terms apply. Rates subject to change. Up to $150 establishment fee and early repayment charges may apply.

*As at 6.30am, 16 April 2025, BNZ has the market leading 18-month fixed rate of the five main banks.

The post BNZ cuts home loan rates, offers market-leading 18-month fixed rate appeared first on BNZ Debrief.

BNZ expands digital payments capability

Source:

BNZ today announced an investment in New Zealand payments technology company Centrapay to enhance digital payments capabilities across both organisations.

It builds on the established partnership between the organisations, which has led to the development of Payap – New Zealand’s first digital wallet and Point of Sale app compatible with all New Zealand banks. Payap is due to be launched in March next year.

Centrapay CEO Greg Beehre will continue to lead the company.

“With BNZ’s support, we can go further, faster. This enables us to continue delivering for our clients and partners while accelerating growth and development,” Beehre says.

BNZ CEO Dan Huggins says the investment builds on BNZ’s existing payments and open banking infrastructure.

“Payment technology continues to evolve rapidly, and our partnership with Centrapay helps further position us to serve our customers’ changing needs.”

The post BNZ expands digital payments capability appeared first on BNZ Debrief.